Clinical Trials Browser

Phase NA × COVID-19 Serological Testing × Lymphoid × Clear all

NCT04862806 2021-09-17

Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL

Phase NA Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell